எங்கள் குழு ஒவ்வொரு ஆண்டும் அமெரிக்கா, ஐரோப்பா மற்றும் ஆசியா முழுவதும் 1000 அறிவியல் சங்கங்களின் ஆதரவுடன் 3000+ உலகளாவிய மாநாட்டுத் தொடர் நிகழ்வுகளை ஏற்பாடு செய்து 700+ திறந்த அணுகல் இதழ்களை வெளியிடுகிறது, இதில் 50000 க்கும் மேற்பட்ட தலைசிறந்த ஆளுமைகள், புகழ்பெற்ற விஞ்ஞானிகள் ஆசிரியர் குழு உறுப்பினர்களாக உள்ளனர்.
அதிக வாசகர்கள் மற்றும் மேற்கோள்களைப் பெறும் திறந்த அணுகல் இதழ்கள்
700 இதழ்கள் மற்றும் 15,000,000 வாசகர்கள் ஒவ்வொரு பத்திரிகையும் 25,000+ வாசகர்களைப் பெறுகிறது
Noorjahan P
Mucosal immune cell trafficking plays a crucial role in maintaining homeostasis and defending against pathogens at various mucosal surfaces, including the respiratory, gastrointestinal, and genitourinary tracts. This review aims to provide insights into the mechanisms underlying mucosal immune cell trafficking, its implications in health and disease, and the therapeutic opportunities it presents. Mucosal immune cell trafficking is a highly regulated process involving intricate interactions between immune cells, endothelial cells, epithelial cells, and chemokines. The trafficking of immune cells to mucosal tissues is governed by a combination of chemotactic gradients, adhesion molecules, and signaling pathways. These mechanisms ensure proper recruitment, retention, and surveillance of immune cells within the mucosal microenvironment. Understanding the implications of mucosal immune cell trafficking is critical for unraveling the pathogenesis of various mucosal diseases, including inflammatory bowel disease, asthma, chronic obstructive pulmonary disease, and sexually transmitted infections. Dysregulation of immune cell trafficking can lead to chronic inflammation, tissue damage, and impaired immune responses. Elucidating the specific mechanisms involved in these diseases can provide valuable targets for therapeutic intervention. Exploiting the knowledge of mucosal immune cell trafficking has opened up new therapeutic opportunities. Strategies aimed at modulating immune cell migration, such as blocking adhesion molecules or inhibiting chemokine receptors, have shown promise in preclinical and clinical studies. Furthermore, targeted delivery of immune cells to specific mucosal sites using engineered nanoparticles or cell-based therapies holds great potential for immunotherapy and vaccine development. In conclusion, understanding the mechanisms, implications, and therapeutic opportunities associated with mucosal immune cell trafficking is crucial for advancing our knowledge of mucosal immunology and developing novel therapeutic approaches. By targeting the processes governing immune cell migration, it may be possible to modulate immune responses, ameliorate chronic inflammatory conditions, and enhance mucosal immune protection. Continued research in this field is essential for improving human health and addressing the challenges posed by mucosal diseases.